PUBLICATIONS ALERT: Three articles focused on optimizing treatment strategies for multidrug-resistant tuberculosis (MDR-TB)

Urgent request for pretomanid label expansion to align with WHO guidelines and improve treatment accessibility and efficacy Efficacy and Safety of Higher Doses of Levofloxacin for MDR-TB: A Randomized Placebo-controlled Phase 2 Trial Study protocol for a duration-randomized clinical trial to determine the optimal length of treatment for multidrug-resistant tuberculosis with a 5-drug regimen: The […]

PUBLICATION ALERT: Costs incurred by people receiving tuberculosis treatment in low-income and middle-income countries: a meta-regression analysis

Check out the latest study by Portnoy et al. (2023) on the economic costs of tuberculosis treatment in low- and middle-income countries. The study delves into the often-overlooked financial burdens faced by patients, even in the presence of ostensibly free treatment. By synthesizing data from 22 national surveys conducted between 2015 and 2022, the authors […]